NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:NRC • US6373722023

15.27 USD
-2.35 (-13.34%)
At close: Feb 4, 2026
15.27 USD
0 (0%)
After Hours: 2/4/2026, 8:00:01 PM
Fundamental Rating

4

Overall NRC gets a fundamental rating of 4 out of 10. We evaluated NRC against 102 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are quite some concerns on its financial health. NRC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NRC was profitable.
  • In the past year NRC had a positive cash flow from operations.
  • Each year in the past 5 years NRC has been profitable.
  • In the past 5 years NRC always reported a positive cash flow from operatings.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

  • NRC has a better Return On Assets (12.06%) than 97.06% of its industry peers.
  • NRC has a Return On Equity of 114.31%. This is amongst the best in the industry. NRC outperforms 99.02% of its industry peers.
  • The Return On Invested Capital of NRC (21.73%) is better than 97.06% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NRC is significantly above the industry average of 9.16%.
  • The last Return On Invested Capital (21.73%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.06%
ROE 114.31%
ROIC 21.73%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

1.3 Margins

  • NRC has a Profit Margin of 11.76%. This is amongst the best in the industry. NRC outperforms 97.06% of its industry peers.
  • In the last couple of years the Profit Margin of NRC has declined.
  • NRC has a better Operating Margin (19.80%) than 97.06% of its industry peers.
  • In the last couple of years the Operating Margin of NRC has declined.
  • NRC's Gross Margin of 62.05% is amongst the best of the industry. NRC outperforms 82.35% of its industry peers.
  • NRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.8%
PM (TTM) 11.76%
GM 62.05%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NRC is creating value.
  • Compared to 1 year ago, NRC has less shares outstanding
  • The number of shares outstanding for NRC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, NRC has a worse debt to assets ratio.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.08 indicates that NRC is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of NRC (3.08) is better than 64.71% of its industry peers.
  • The Debt to FCF ratio of NRC is 6.31, which is on the high side as it means it would take NRC, 6.31 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NRC (6.31) is comparable to the rest of the industry.
  • NRC has a Debt/Equity ratio of 5.31. This is a high value indicating a heavy dependency on external financing.
  • NRC's Debt to Equity ratio of 5.31 is on the low side compared to the rest of the industry. NRC is outperformed by 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.31
Debt/FCF 6.31
Altman-Z 3.08
ROIC/WACC2.5
WACC8.71%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

  • NRC has a Current Ratio of 0.53. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.53, NRC is not doing good in the industry: 85.29% of the companies in the same industry are doing better.
  • NRC has a Quick Ratio of 0.53. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NRC has a Quick ratio of 0.53. This is amonst the worse of the industry: NRC underperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • NRC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
  • NRC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.24% yearly.
  • NRC shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
  • The Revenue has been growing slightly by 4.42% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.22 indicates a correct valuation of NRC.
  • Based on the Price/Earnings ratio, NRC is valued cheaper than 84.31% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, NRC is valued rather cheaply.
Industry RankSector Rank
PE 12.22
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • NRC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NRC is cheaper than 66.67% of the companies in the same industry.
  • NRC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.28
EV/EBITDA 12.27
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.77
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.63%, NRC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.47, NRC pays a better dividend. On top of this NRC pays more dividend than 98.04% of the companies listed in the same industry.
  • NRC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

  • The dividend of NRC decreases each year by -17.40%.
  • NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • 65.02% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
DP65.02%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NATIONAL RESEARCH CORP

NASDAQ:NRC (2/4/2026, 8:00:01 PM)

After market: 15.27 0 (0%)

15.27

-2.35 (-13.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners49.6%
Inst Owner Change-1.95%
Ins Owners10.45%
Ins Owner Change2.71%
Market Cap346.02M
Revenue(TTM)148.58M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.27%
Short Ratio4.7
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP65.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.22
Fwd PE N/A
P/S 2.49
P/FCF 27.28
P/OCF 13.17
P/B 24.17
P/tB N/A
EV/EBITDA 12.27
EPS(TTM)1.25
EY8.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.56
FCFY3.67%
OCF(TTM)1.16
OCFY7.59%
SpS6.14
BVpS0.63
TBVpS-2.39
PEG (NY)N/A
PEG (5Y)3.77
Graham Number4.21
Profitability
Industry RankSector Rank
ROA 12.06%
ROE 114.31%
ROCE 28.35%
ROIC 21.73%
ROICexc 22.24%
ROICexgc 79.8%
OM 19.8%
PM (TTM) 11.76%
GM 62.05%
FCFM 9.12%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 5.31
Debt/FCF 6.31
Debt/EBITDA 2.2
Cap/Depr 194.38%
Cap/Sales 9.77%
Interest Coverage 7.13
Cash Conversion 76.08%
Profit Quality 77.53%
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z 3.08
F-Score6
WACC8.71%
ROIC/WACC2.5
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.08%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.24%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-23.9%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%

NATIONAL RESEARCH CORP / NRC FAQ

What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NRC.


Can you provide the valuation status for NATIONAL RESEARCH CORP?

ChartMill assigns a valuation rating of 4 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Fairly Valued.


What is the profitability of NRC stock?

NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.


What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?

The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 12.22 and the Price/Book (PB) ratio is 24.17.


Can you provide the financial health for NRC stock?

The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.